speb/financial-data huggingface dataset:
LABS.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 413000.00
LABS.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -4861000.00
LABS.TO cash_flow (annual, 2024-12-31) — Change In Inventory: 663000.00
LABS.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 272000.00
LABS.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 413000.00
LABS.TO cash_flow (annual, 2024-12-31) — Change In Payable: 1867000.00
LABS.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1867000.00
LABS.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -1563000.00
LABS.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 1652000.00
LABS.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1563000.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -793000.00
LABS.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -6295000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Common Stock: 201210000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 43184000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 45000.00
LABS.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 29156000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1688000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Assets: 33082000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 79000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Debt: 258000.00
LABS.TO balance_sheet (quarterly, 2024-12-31) — Current Debt: 258000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 337000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 607000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 607000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 10495000.00
LABS.TO cash_flow (annual, 2024-12-31) — Depreciation: 2422000.00
LABS.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2600000.00
LABS.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 431000.00
LABS.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2600000.00
LABS.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 431000.00
LABS.TO income_statement (annual, 2024-12-31) — Depreciation Income Statement: 431000.00
LABS.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 407993353.00
LABS.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.03
LABS.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -10694000.00
LABS.TO income_statement (annual, 2024-12-31) — EBIT: -10118000.00
LABS.TO income_statement (annual, 2024-12-31) — EBITDA: -7518000.00
LABS.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 4000.00
LABS.TO cash_flow (annual, 2024-12-31) — End Cash Position: 11690000.00
LABS.TO income_statement (annual, 2024-12-31) — Excise Taxes: 3244000.00
LABS.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1847000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 5922000.00
LABS.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -5015000.00
LABS.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
LABS.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -296000.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
LABS.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
LABS.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 296000.00
LABS.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 46000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 29400000.00
LABS.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 19812000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 854000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 6956000.00
LABS.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 6956000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 42482000.00
LABS.TO income_statement (annual, 2024-12-31) — Gross Profit: 12805000.00
LABS.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 70000.00
LABS.TO income_statement (annual, 2024-12-31) — Insurance And Claims: 391000.00
LABS.TO income_statement (annual, 2024-12-31) — Interest Expense: 576000.00
LABS.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 576000.00
LABS.TO income_statement (annual, 2024-12-31) — Interest Income: 691000.00
LABS.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 691000.00
LABS.TO cash_flow (annual, 2024-12-31) — Interest Paid Cff: -300000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Inventory: 8710000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 43442000.00
LABS.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 413000.00
LABS.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 799000.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
LABS.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 1863000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Leases: 209000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 51000.00
LABS.TO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 51000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 51000.00
LABS.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 51000.00
LABS.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 799000.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
LABS.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -136000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 14364000.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -51000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Income: -10694000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -10694000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -10694000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -10694000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -10694000.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -10694000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -10694000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Interest Income: 115000.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2252000.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 663000.00
LABS.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 115000.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 691000.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 220000.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
LABS.TO balance_sheet (annual, 2024-12-31) — Net PPE: 19159000.00
LABS.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 193000.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
LABS.TO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -2915000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 42330000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 635000.00
LABS.TO balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 635000.00
LABS.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -7600000.00
LABS.TO income_statement (annual, 2024-12-31) — Normalized Income: -10776000.00
LABS.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -4861000.00
LABS.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -347000.00
LABS.TO income_statement (annual, 2024-12-31) — Operating Income: -10891000.00
LABS.TO income_statement (annual, 2024-12-31) — Operating Revenue: 45205000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 415048645.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 213000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 258000.00
LABS.TO balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 258000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 29400000.00
LABS.TO income_statement (annual, 2024-12-31) — Other Gand A: 6554000.00
LABS.TO income_statement (annual, 2024-12-31) — Other Income Expense: 82000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 854000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Inventories: 147000.00
LABS.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 569000.00
LABS.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 257000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Payable: 826000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Properties: 738000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 32000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Payables: 5063000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 6751000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2800000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 609000.00
LABS.TO income_statement (annual, 2024-12-31) — Pretax Income: -10694000.00
LABS.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 14000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
LABS.TO income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: -83000.00
LABS.TO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -83000.00
LABS.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -154000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 2641000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Receivables: 7512000.00
LABS.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 26987000.00
LABS.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2600000.00
LABS.TO income_statement (annual, 2024-12-31) — Rent And Landing Fees: 608000.00
LABS.TO income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 608000.00
LABS.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3051000.00
LABS.TO income_statement (annual, 2024-12-31) — Research And Development: 235000.00
LABS.TO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
LABS.TO income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
LABS.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -187426000.00
LABS.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 12259000.00
LABS.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
LABS.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 347000.00
LABS.TO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
LABS.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 3044000.00
LABS.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 22856000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Share Issued: 415048645.00
LABS.TO cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -2915000.00
LABS.TO income_statement (annual, 2024-12-31) — Special Income Charges: 36000.00
LABS.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: -296000.00
LABS.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 976000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 43184000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 42330000.00
LABS.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
LABS.TO income_statement (annual, 2024-12-31) — Tax Provision: 0.00
LABS.TO income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
LABS.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
LABS.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 602000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Total Assets: 53730000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 43184000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Total Debt: 388000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 43184000.00
LABS.TO income_statement (annual, 2024-12-31) — Total Expenses: 52852000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 10546000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 20648000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 51000.00
LABS.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -10809000.00
LABS.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 82000.00
LABS.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: -241000.00
LABS.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 82000.00
LABS.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -241000.00
LABS.TO balance_sheet (annual, 2024-12-31) — Working Capital: 22587000.00
LABS.TO income_statement (annual, 2024-12-31) — Write Off: 190000.00
LABS.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 5083000.00
LABS.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 10806000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4890000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7407000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -23703000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 45000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 45000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 28000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 4348000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 415123632.00
LABS.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 11690000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 24973000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -42000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -42000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 111000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 201216000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 8443000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8443000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -209000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -42000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3012000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -1866000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 198000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -2083000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 635000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 635000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -281000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -3397000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -281000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3263000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 201216000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 43232000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
LABS.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6164000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1953000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 31802000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 80000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 14000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 94000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 568000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 568000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 8804000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 380000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 425000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 425000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 415123632.00
LABS.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
LABS.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -387000.00
LABS.TO income_statement (quarterly, 2025-03-31) — EBIT: -371000.00
LABS.TO income_statement (quarterly, 2025-03-31) — EBITDA: 54000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 16000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 8443000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Excise Taxes: 723000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -209000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 6348000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3054000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 29829000.00
LABS.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3480000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 809000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 42524000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 4642000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 16000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 16000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Interest Income: 70000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 70000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -14000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 10594000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 43246000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -42000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1863000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Leases: 209000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 31000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 31000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -265000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 14451000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -11000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Income: -387000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -387000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -387000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -387000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -387000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -387000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -387000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 54000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -265000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -265000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 54000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 70000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 18821000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 42423000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 635000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 54000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -387000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3012000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -11000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Operating Income: -441000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 11529000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 415138973.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 268000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 14000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 29829000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 3043000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 809000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Inventories: 172000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -100000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -184000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 1082000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 1028000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 20000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Payables: 5972000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 7925000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 217000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 356000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -387000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -7000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 4074000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 7793000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6164000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 425000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 413000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -265000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Research And Development: 78000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -187813000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 437000.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
LABS.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1709000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 5189000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 415138973.00
LABS.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 437000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 43232000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 42423000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LABS.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 366000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 52067000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 43232000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 125000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 43232000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 11247000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 8835000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 20265000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 31000.00
LABS.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -441000.00
LABS.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 22998000.00
LABS.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 7130000.00
LABS.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 11808000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4614000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 7042000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -24077000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -15000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 165000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 474000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 415350206.00
LABS.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.01
LABS.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 8443000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 25263000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -42000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -42000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 92000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 201637000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 10362000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 10362000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 447000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 4203000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2769000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1253000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -595000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 356000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -512000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -512000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -230000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 272000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1881000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 201637000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 39817000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 0.00
LABS.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8478000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1778000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 29516000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 82000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 450000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 532000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 497000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 497000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 9481000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 419000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 419000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 415350206.00
LABS.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.01
LABS.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -3770000.00
LABS.TO income_statement (quarterly, 2025-06-30) — EBIT: -3758000.00
LABS.TO income_statement (quarterly, 2025-06-30) — EBITDA: -3339000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 38000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 10362000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Excise Taxes: 804000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 447000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 5086000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2811000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 24668000.00
LABS.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 5793000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 764000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 7057000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 42566000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 3330000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 12000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 12000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Interest Income: 42000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 42000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -11000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 9350000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 40267000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 4203000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 1863000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Leases: 209000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 10000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 10000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 224000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 14493000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 22000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Income: -3770000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -3770000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3770000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3770000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3770000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3770000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -3770000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 30000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 416000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 224000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 30000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 42000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 18489000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 39053000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 539000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3339000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -3770000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2769000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -249000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Operating Income: -3800000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 12612000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 420755012.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 299000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 450000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 24668000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 5291000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 764000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Inventories: 221000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -123000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -78000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 1002000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 738000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 283000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Payables: 5616000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 7394000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1058000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1016000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -3770000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 15000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 4043000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 8015000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8478000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 419000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 267000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -84000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Research And Development: 46000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -186488000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 502000.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
LABS.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1369000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 7162000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 420755012.00
LABS.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 502000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 39817000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 39053000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
LABS.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 690000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 49308000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 39817000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 542000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 39817000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 15608000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9491000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 19792000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 10000.00
LABS.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3800000.00
LABS.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 20035000.00
LABS.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 4750000.00
LABS.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 11448000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4736000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 6620000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -23986000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -20000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 34000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
LABS.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 420755012.00
LABS.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
LABS.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 10362000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 25263000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -16000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -16000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 72000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 201637000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10584000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10584000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -73000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 459000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -158000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 1387000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 308000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -643000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 32000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 32000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 286000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1370000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 228000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 201637000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 37861000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 10000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8886000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1771000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 27930000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 72000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 351000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 423000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 530000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 530000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 8736000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 420000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 420000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 420755012.00
LABS.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
LABS.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2142000.00
LABS.TO income_statement (quarterly, 2025-09-30) — EBIT: -2126000.00
LABS.TO income_statement (quarterly, 2025-09-30) — EBITDA: -1706000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -6000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 10584000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Excise Taxes: 770000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -73000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 4651000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -174000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 147000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -98000.00
LABS.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3359000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 720000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 6640000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 41933000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 2562000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 16000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 16000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Interest Income: 62000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 62000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -15000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 8102000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 38212000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 459000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 1863000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Leases: 209000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 0.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -428000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 13850000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -1000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Income: -2142000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2142000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2142000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2142000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2142000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2142000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2142000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 46000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -120000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 72000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 46000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 62000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 440000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 17947000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 35000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 37141000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 0.00
LABS.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1706000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -2142000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -158000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 146000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Operating Income: -2188000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 12218000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 420755012.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 288000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 351000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -98000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 24952000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 3165000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 720000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Inventories: 172000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -185000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 189000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Payable: 755000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 738000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 106000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Payables: 5491000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 7262000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 521000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 1233000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -2142000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00